l-tetrahydropalmatine

Small moleculeexperimental

Clinical trial activity

3 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2012 (NCT01631383)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • l-tetrahydropalmatine
  • l-tetrahydropalmatine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02118610N/ASep 1, 2014Stanley Medical Research Institute, University of Maryland, University of Maryland, Baltimore County
NCT02139761Phase 2Sep 1, 2014National Institute on Drug Abuse (NIDA), University of Maryland
NCT01631383Phase 1Oct 1, 2012National Institute on Drug Abuse (NIDA), University of Maryland
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of MarylandAcademic/Hospital3332012
National Institute on Drug Abuse (NIDA)Government2022012
Stanley Medical Research InstituteAcademic/Hospital1012014
University of Maryland, Baltimore CountyAcademic/Hospital1012014
4 organizations
Page 1 / 1